Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,425 | -3,127 | -20,774 | -17,507 | -11,546 |
| Depreciation Amortization | 51 | 25 | 117 | 170 | 158 |
| Accounts receivable | N/A | N/A | 300 | 300 | 300 |
| Other Working Capital | 3,458 | -395 | 92 | 177 | 995 |
| Other Operating Activity | 1,113 | 690 | 4,508 | 3,683 | 1,194 |
| Operating Cash Flow | $-1,803 | $-2,807 | $-15,757 | $-13,178 | $-8,898 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -99 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-99 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -29 | 300 | 300 | N/A |
| Debt Issued | 224 | 224 | N/A | N/A | N/A |
| Debt Repayment | -166 | -51 | -297 | -219 | -130 |
| Common Stock Issued | 15,888 | 2,853 | 4,008 | 1,060 | N/A |
| Financing Cash Flow | $15,946 | $2,998 | $4,012 | $1,141 | $-130 |
| Beginning Cash Position | 1,355 | 1,355 | 13,100 | 13,100 | 13,100 |
| End Cash Position | 15,400 | 1,546 | 1,355 | 1,063 | 4,072 |
| Net Cash Flow | $14,044 | $191 | $-11,745 | $-12,037 | $-9,028 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,803 | -2,807 | -15,757 | -13,178 | -8,898 |
| Capital Expenditure | -99 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -1,902 | -2,807 | -15,757 | -13,178 | -8,898 |